BRPI0706871A2 - uso de um extrato de sambucus nigra l., método de tratamento de uma infecção viral de influenza e método de inibição da infecção viral de influenza - Google Patents

uso de um extrato de sambucus nigra l., método de tratamento de uma infecção viral de influenza e método de inibição da infecção viral de influenza

Info

Publication number: BRPI0706871A2
Authority: BR; Brazil
Prior art keywords: viral infection; influenza viral; extract; treatment; sambucus nigra
Prior art date: 2006-01-17

Application number

BRPI0706871A

Other languages

English (en)

Inventor

Madeleine Mumcuoglu

Original Assignee

Healthcare Brands Internat Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-01-17

Filing date

2007-01-17

Publication date

2016-08-09

2007-01-17 Application filed by Healthcare Brands Internat Ltd filed Critical Healthcare Brands Internat Ltd

2016-08-09 Publication of BRPI0706871A2 publication Critical patent/BRPI0706871A2/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Natural Medicines & Medicinal Plants (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Virology (AREA)
Mycology (AREA)
Alternative & Traditional Medicine (AREA)
Epidemiology (AREA)
Microbiology (AREA)
Biotechnology (AREA)
Botany (AREA)
Medical Informatics (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Pulmonology (AREA)
Molecular Biology (AREA)
Medicines Containing Plant Substances (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicinal Preparation (AREA)

BRPI0706871A 2006-01-17 2007-01-17 uso de um extrato de sambucus nigra l., método de tratamento de uma infecção viral de influenza e método de inibição da infecção viral de influenza BRPI0706871A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IL173207A IL173207A0 (en)	2006-01-17	2006-01-17	Treatment of avian flu with black elderberry extract
PCT/GB2007/000150 WO2007083123A1 (en)	2006-01-17	2007-01-17	Use of elderberry extract

Publications (1)

Publication Number	Publication Date
BRPI0706871A2 true BRPI0706871A2 (pt)	2016-08-09

Family

ID=38002208

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0706871A BRPI0706871A2 (pt)	2006-01-17	2007-01-17	uso de um extrato de sambucus nigra l., método de tratamento de uma infecção viral de influenza e método de inibição da infecção viral de influenza

Country Status (12)

Country	Link
US (1)	US20090186101A1 (pt)
EP (1)	EP1976543A1 (pt)
KR (1)	KR20080084992A (pt)
CN (1)	CN101384271A (pt)
AU (1)	AU2007206780A1 (pt)
BR (1)	BRPI0706871A2 (pt)
CA (1)	CA2632768A1 (pt)
IL (2)	IL173207A0 (pt)
MX (1)	MX2008009117A (pt)
NO (1)	NO20083139L (pt)
RU (1)	RU2008130825A (pt)
WO (1)	WO2007083123A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2007109600A2 (en) *	2006-03-17	2007-09-27	Herbalscience Singapore Pte. Ltd.	Extractions and methods comprising elder species
FR2937252B1 (fr) *	2008-10-17	2011-05-20	Pf Medicament	Association d'un extrait de sureau et d'une souche de l. paracasei.
US9440866B2 (en)	2011-06-06	2016-09-13	Axine Water Technologies	Efficient treatment of wastewater using electrochemical cell
KR102128134B1 (ko)	2012-12-03	2020-06-30	악신 워터 테크놀로지스 아이엔씨.	전기화학 전지를 이용하는 효율적인 폐수 처리
KR102080410B1 (ko) *	2018-10-31	2020-02-21	주식회사 코사바이오	엘더베리 추출물을 유효성분으로 함유하는 남성 갱년기 증후군의 예방, 치료 또는 개선용 조성물
KR20200048862A (ko) *	2018-10-31	2020-05-08	주식회사 코사바이오	엘더베리 추출물을 유효성분으로 함유하는 남성 난임의 예방, 치료 또는 개선용 조성물
JP2023547727A (ja) *	2020-11-04	2023-11-13	ボブズシルバー	経鼻投与用消毒剤組成物
US20240269219A1 (en) *	2021-04-02	2024-08-15	Aronpharma Sp. Z O.O.	Pharmaceutical composition and its antiviral use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4742046A (en) *	1984-08-03	1988-05-03	Medisearch S.A.	Methods and compositions for inhibiting the infectious activity of viruses
JP2000229870A (ja) *	1999-02-15	2000-08-22	Biogurippu Sl	ウイルス起源のヒト疾患を治療するために使用される医薬品を得るための基剤として使用される抽出物の調製方法
FR2825927B1 (fr) *	2001-06-13	2004-08-06	Hotchen Myriam	Composition antivirale incorporant des lectines
KR20030027133A (ko) *	2001-09-12	2003-04-07	최달정	블렉엘더베리를 주원료로하며 인풀루엔자 바이러스 감염의예방 및 퇴치를 위한 건강기능식품 또는 약품 제조방법

2006
- 2006-01-17 IL IL173207A patent/IL173207A0/en unknown
2007
- 2007-01-17 CA CA002632768A patent/CA2632768A1/en not_active Abandoned
- 2007-01-17 BR BRPI0706871A patent/BRPI0706871A2/pt not_active IP Right Cessation
- 2007-01-17 CN CNA2007800020319A patent/CN101384271A/zh active Pending
- 2007-01-17 US US12/159,691 patent/US20090186101A1/en not_active Abandoned
- 2007-01-17 EP EP07704932A patent/EP1976543A1/en not_active Withdrawn
- 2007-01-17 KR KR1020087015986A patent/KR20080084992A/ko not_active Withdrawn
- 2007-01-17 RU RU2008130825/15A patent/RU2008130825A/ru unknown
- 2007-01-17 WO PCT/GB2007/000150 patent/WO2007083123A1/en not_active Ceased
- 2007-01-17 AU AU2007206780A patent/AU2007206780A1/en not_active Abandoned
- 2007-01-17 MX MX2008009117A patent/MX2008009117A/es not_active Application Discontinuation
2008
- 2008-07-08 IL IL192700A patent/IL192700A0/en unknown
- 2008-07-15 NO NO20083139A patent/NO20083139L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
NO20083139L (no)	2008-07-15
KR20080084992A (ko)	2008-09-22
AU2007206780A1 (en)	2007-07-26
EP1976543A1 (en)	2008-10-08
CN101384271A (zh)	2009-03-11
IL173207A0 (en)	2006-06-11
IL192700A0 (en)	2009-09-22
RU2008130825A (ru)	2010-02-27
WO2007083123A1 (en)	2007-07-26
MX2008009117A (es)	2008-11-14
US20090186101A1 (en)	2009-07-23
CA2632768A1 (en)	2007-07-26

Similar Documents

Publication	Publication Date	Title
BRPI0916235A2 (pt)	2018-03-13	composto, composição farmacêutica, uso do composto ou da composição, e, método para tratar um paciente infectado com hcv
BRPI0920026A2 (pt)	2015-12-15	método de tratamento de infecção pulmonar, composição farmacêutica e respectivos usos.
BRPI0706871A2 (pt)	2016-08-09	uso de um extrato de sambucus nigra l., método de tratamento de uma infecção viral de influenza e método de inibição da infecção viral de influenza
BRPI1013394A2 (pt)	2016-06-21	"composto, composição farmacêutica, uso do composto, e, método para tratar um paciente infectado com virus da hepatite c."
BRPI0809663A2 (pt)	2014-10-14	Composição de vírus vivo atenuado, método de diminuição da inativação de composição de vírus vivo atenuado e kit respectivo
EP2497482A4 (en)	2013-05-01	COMPOSITION FOR PROPHYLAXIS AND TREATMENT OF INFLUENZA AVIRUSED INDUCED DISEASES
CL2012001176A1 (es)	2012-08-31	Compuestos derivados de bencimidazol-imidazol, inhibidores del virus de la hepatitis c (hcv); composición farmacéutica que los comprende; combinación farmacéutica; uso en la prevención o tratamiento de infección de hcv.
BR112013011737A2 (pt)	2016-08-09	composto, uso de um composto composição farmacêutica, e, método de tratamento ou prevenção de uma infecção por hiv
CR11731A (es)	2011-06-08	Composiciones y procedimientos para su preparación y uso
BRPI0820183A2 (pt)	2015-06-23	Prevenção e tratamento de infecções secundárias após infecção viral
PT2109602E (pt)	2014-05-23	Derivados de tetraciclina para o tratamento de infecções bacterianas, virais e parasitárias
EP2046290A4 (en)	2011-08-17	AQUEOUS DRONABINOL FORMULATIONS
IL186611A0 (en)	2008-01-20	Vaccine against pandemic strains of influenza viruses
PL2281830T3 (pl)	2017-06-30	Szczepionka przeciw wirusowi ospy wietrznej i półpaśca
BRPI0913726A2 (pt)	2015-10-13	rapalogs, composições farmacêuticas, métodos de preparo e uso dos mesmos
CL2012000573A1 (es)	2012-08-31	Compuestos derivados de bifenil-pirrolidinil-imidazol; composicion farmaceutica que los comprende; su uso en el tratamiento de una infeccion viral por hcv.
IL202450A (en)	2015-05-31	Pharmaceutical composition to treat influenza virus infection
SG179082A1 (en)	2012-04-27	Method for the preparation of an influenza virus
EP2078083A4 (en)	2009-10-28	NEW DOG INFLUENZA VIRUS AND VEGETABLE THEREFOR
BRPI0814899A2 (pt)	2015-02-03	Composição, vacina, metodo para amenizar um ou mais sintomas associados à infecção com o virus da influenza em um individuo e método para reduzir a probabilidade de infecção com o virus da influeza em um individuo"
BRPI0811870A2 (pt)	2014-10-21	Tratamento e prevenção de influenza
CL2008001740A1 (es)	2009-07-17	Compuestos derivados de piperidinas sustituidas, inhibidores de la dna-girasa y/o topoisomerasa iv; procedimeinto para su preparacion; composiicon farmaceutica que comprende estos compustos y su uso en el tratamiento de una infeccion bacteriana.
BRPI0607198A2 (pt)	2016-11-01	composição, uso da composição método de tratamento doenças, e, embalagem farmacêutica
EA201290373A1 (ru)	2012-11-30	Синергическая противовирусная композиция и ее применение
DK3006038T3 (da)	2024-08-26	Enkeltdoser af oritavancin til behandling eller forebyggelse af en bakterieinfektion

Legal Events

Date	Code	Title	Description
2011-03-09	B11Z	Dismissal: petition dismissal - article 216, par 2 of industrial property law	Free format text: REFERENTE A PETICAO NO 018080045074 DE 16/07/2008.
2016-07-26	B11M	Decision cancelled [chapter 11.13 patent gazette]	Free format text: FOI ANULADA A PUBLICACAO 11.6.1 DA RPI 2096 DE 09/03/2011 POR TER SIDO INDEVIDA.
2016-09-13	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE AS 5A, 6A, 7A, 8A E 9A ANUIDADES.
2017-01-10	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2384 DE 13-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.